Legend:
CC = Vancouver Convention Centre
F = Fairmont Waterfront Vancouver
* = applied session ! = JSM meeting theme
|
|
|
|
469 *
|
Wed, 8/1/2018,
8:30 AM -
10:20 AM
|
CC-West 119
|
|
Novel Trial Designs in Precision Medicine — Topic Contributed Papers
|
|
Biopharmaceutical Section
|
|
Organizer(s): Jianchang Lin, Takeda Pharmaceuticals
|
|
Chair(s): Rachael Liu, Takeda Pharmaceuticals
|
|
8:35 AM
|
Subgroup Selection in Adaptive Signature Designs of Confirmatory Clinical Trials
Zhiwei Zhang, University of California at Riverside
|
|
8:55 AM
|
A Case Study of Adaptive Seamless Design with Subpopulation Selection in Oncology
Rui Qin, Janssen Pharmaceutical R&D
|
|
9:15 AM
|
REMAP-CAP: a Precision Medicine Embedded Platform Trial for Community Acquired Pneumonia
Scott Berry, Berry Consultants
|
|
9:35 AM
|
A Biomarker-Directed Phase 2 Oncology Umbrella Trial to Target Combination Therapy in NSCLC
Hua Ma, Merck; Robin Mogg, Merck Research Laboratories
|
|
9:55 AM
|
Adaptive Multi-Combination Platform Trials in Oncology; Considerations for Study Designs
Stuart Bailey, Novartis Institutes for Biomed Research; Jennifer Gauvin, Novartis
|
|
10:15 AM
|
Floor Discussion
|
